Cargando…
Pleural effusion as a substitute for tumor tissue in detecting EGFR/ALK mutations in non-small cell lung cancer: A systematic review and meta-analysis
BACKGROUND: Pleural effusion (PE) has been reported useful in many studies for testing epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) with variable results. This systematic review and meta-analysis was performed to elucidate whether PE could be used as a surr...
Autores principales: | Pang, Caishuang, Ma, Huiwen, Qin, Jiangyue, Wang, Sixiong, Wan, Chun, Yang, Ting, Shen, Yongchun, Wang, Donglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504331/ https://www.ncbi.nlm.nih.gov/pubmed/31045816 http://dx.doi.org/10.1097/MD.0000000000015450 |
Ejemplares similares
-
Incidence of complications from indwelling pleural catheter for pleural effusion: A meta‐analysis
por: Wang, Shuyan, et al.
Publicado: (2022) -
Detecting EGFR mutations and ALK/ROS1 rearrangements in non‐small cell lung cancer using malignant pleural effusion samples
por: Yao, Yi, et al.
Publicado: (2018) -
Malignant Pleural Effusion Supernatants Are Substitutes for Metastatic Pleural Tumor Tissues in EGFR Mutation Test in Patients with Advanced Lung Adenocarcinoma
por: Liu, Dan, et al.
Publicado: (2014) -
Alectinib-Induced Pleural and Pericardial Effusions in ALK-Positive NSCLC
por: Ulhoi, Maiken Parm, et al.
Publicado: (2021) -
Diagnostic value of interleukins for tuberculous pleural effusion: a systematic review and meta-analysis
por: Zeng, Ni, et al.
Publicado: (2017)